VOCASEPT PLUS LOZENGES

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
11-04-2022

Toimeaine:

dichlorobenzyl alcohol, Quantity: 1.2 mg; lidocaine hydrochloride monohydrate, Quantity: 10 mg; amylmetacresol, Quantity: 0.6 mg

Saadav alates:

Mapaex Consumer Healthcare (Australia) Pty Ltd

Ravimvorm:

Lozenge

Koostis:

Excipient Ingredients: glucose; tartaric acid; saccharin sodium; Mentha X piperita; quinoline yellow; purified water; menthol; sucrose; Flavour

Manustamisviis:

Oral

Ühikuid pakis:

8,12,16,24,32,36

Retsepti tüüp:

Not scheduled. Not considered by committee

Näidustused:

For the symptomatic relief of minor mouth and throat infections, including sore throat and the relief of symptoms of inflammation.

Toote kokkuvõte:

Visual Identification: A yellow coloured, round, flat bevelled lozenges.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Volitamisolek:

Registered

Loa andmise kuupäev:

2022-02-07